Security key
75629V104
RECURSION PHARMACEUTICALS, INC. - COMMON STOCK (RXRX)
CUSIP: 75629V104
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 251,836,128
- Total 13F value
- $1,888,574,788
- Share change
- +40,762,649
- Put/Call ratio
- 248%
- SEC-reported price per share
- $7.50
- Number of holders
- 264
- Value change
- +$298,622,706
- Number of buys
- 174
- Number of sells
- 94
- Shares outstanding
- 525,850,455
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
264
Top holders
10
RXRX full security history
Ownership snapshot
Full 13F holder table
RECURSION PHARMACEUTICALS, INC. SEC filings
RECURSION PHARMACEUTICALS, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of RXRX - RECURSION PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Lux Ventures IV, L.P.
Disclosed value leader
BAILLIE GIFFORD & CO
Comparable rows
0/15
Latest evidence
31 Mar 2024
3/4/5
13F
Highest disclosed value: $510,235,627
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BAILLIE GIFFORD & CO has the largest disclosed position value at $510.24M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAILLIE GIFFORD & CO's linked filing trail.
Disclosed position value
Top 5
Lux Ventures IV, L.P.
$137.71M
Mubadala Investment Co PJSC
$137.33M
Zachary Bogue
$39.51M
MIC Capital Partners (Public) Par...
$14.69M
BAILLIE GIFFORD & CO
$510.24M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Lux Ventures IV, L.P. |
3/4/5
Former 10% Owner
|
—
denominator unverified
|
$137,710,376
13,021,519 shares
|
— | 07 Dec 2021 |
| Mubadala Investment Co PJSC |
3/4/5
13F
10%+ Owner · Company
|
—
denominator unverified
|
$137,333,970
12,985,927 shares
|
— | 02 Mar 2023 |
| Zachary Bogue |
3/4/5
Director, 10%+ Owner
|
—
denominator unverified
|
$39,514,048
3,736,341 shares
|
— | 03 Jul 2023 |
| MIC Capital Partners (Public) Parallel Cayman, LP |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$14,688,335
1,388,889 shares
|
— | 01 Nov 2021 |
| BAILLIE GIFFORD & CO |
13F
Company
|
—
mixed-class rows
|
$510,235,627
257,067,477 shares
mixed-class rows
|
— | 31 Mar 2024 |
| ARK Investment Management LLC |
13F
Company
|
—
mixed-class rows
|
$465,081,992
214,194,469 shares
mixed-class rows
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
264
Shares
251,836,128
Rows available
264
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
242
Q2 2024 holders
264
Holder diff
22
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|